Cargando…
Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification
Ankylosing spondylitis (AS) is chronic inflammatory arthritis with a progressive fusion of axial joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress inflammation but do not effectively halt the progression of spine fusion in AS patients. Here we report that the autoimmu...
Autores principales: | Yu, Tao, Zhang, Jianguo, Zhu, Wei, Wang, Xiao, Bai, Yun, Feng, Bin, Zhuang, Qianyu, Han, Chang, Wang, Shengru, Hu, Qimiao, An, Senbo, Wan, Mei, Dong, Shiwu, Xu, Jianzhong, Weng, Xisheng, Cao, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969928/ https://www.ncbi.nlm.nih.gov/pubmed/33731675 http://dx.doi.org/10.1038/s41413-021-00140-6 |
Ejemplares similares
-
Trends of Ankylosing Spondylitis Ossification
por: Rozin, Alexander P
Publicado: (2013) -
STAT3 and SPI1, may lead to the immune system dysregulation and heterotopic ossification in ankylosing spondylitis
por: Liang, Tuo, et al.
Publicado: (2022) -
miR-17-5p Regulates Heterotopic Ossification by Targeting ANKH in Ankylosing Spondylitis
por: Qin, Xiong, et al.
Publicado: (2019) -
Mesenchymal Stem Cells in Heterotopic Ossification in Ankylosing Spondylitis: A Bibliometric Study Based on CiteSpace and VOSViewer
por: Liu, Zhaoyi, et al.
Publicado: (2023) -
Ankylosing spondylitis: etiology, pathogenesis, and treatments
por: Zhu, Wei, et al.
Publicado: (2019)